Trials / Completed
CompletedNCT03346941
Side Effects After Direct-acting Antiviral Treatment
Side Effects After Direct-acting Antiviral Treatment in Patients With Chronic Hepatitis C. The EFINO-C Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 95 (actual)
- Sponsor
- Hospices Civils de Lyon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this study was to assess the incidence of side effects after direct-acting antiviral therapy in patients with chronic hepatitis C virus infection.
Detailed description
Direct-acting antiviral (DAA)-based treatments are today very effective The objective of this study was to assess the incidence of side effects after DAA therapy in patients with chronic hepatitis C virus infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | DAA treatment | Direct-acting antiviral-based treatment |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2017-09-30
- Completion
- 2017-10-31
- First posted
- 2017-11-20
- Last updated
- 2017-11-20
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT03346941. Inclusion in this directory is not an endorsement.